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With the advances in surgical treatment, antibiotic therapy and the current resources for
accurate  diagnosis and differentiated approaches to each type of osteomyelitis, better results
are  being obtained in the treatment of this disease. After a careful literature review carried
out  by a multiprofessional team, some conclusions were made in order to guide medical
approach  to different types of osteomyelitis, aiming to obtain better clinical outcomes and
reducing  the social costs of this disease. Acute and chronic osteomyelitis are discussed, with
presentation of the general epidemiological concepts and the commonly used classiﬁcation
systems.  The main guidelines for the clinical, laboratory and imaging diagnosis of infectionsSoft  tissue infection
Infectious diseases
are  discussed, as well as the guidelines for surgical and antimicrobial treatments, and the
role  of hyperbaric oxygen as adjuvant therapy.
© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDBackground
With the advances in surgical treatment, antibiotic therapy,
and  the current resources for accurate diagnosis and differen-
tiated  approaches to each type of osteomyelitis, better results
are  being obtained in the treatment of this disease. On the
other  hand, as a result of high-energy trauma with extensive
damage  to soft tissues requiring more  aggressive treatments
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1413-8670/© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licençafor open and closed fractures, we have seen a higher number
of  infections arising from surgical procedures related to these
traumatic  lesions, which often take the form of post-traumatic
osteomyelitis and serious soft-tissue infections. In this sce-
nario,  with the progressive increase in traumatic injuries and
their  associated complications, osteomyelitis – particularlya 311a, 05403-010, São Paulo, SP, Brazil.
 de las Osteomielitis e Infecciones de Tejidos Blandos Group are
post-traumatic osteomyelitis – is a signiﬁcant public health
problem.  The objective of this review article is to indicate some
recommendations based on scientiﬁc evidence that will guide
 de CC BY-NC-ND
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Table 1 – Waldvogel classiﬁcation of osteomyelitis.
Characteristics
Mechanism of bone infection
Hematogenous  Secondary to bacterial transport through
the blood. Majority of infections in
children
Contiguous Bacterial inoculation from an adjacent
focus.  E.g.: Post-traumatic Osteomyelitis,
infections  related to prosthetic devices
Associated  with
vascular
insufﬁciency
Infections  affecting the feet in patients
with  diabetes, hanseniasis or peripheral
vascular  insufﬁciency
Duration of infection
Acute  Initial episodes of osteomyelitis. Edema,
formation of pus, vascular congestion,
thrombosis  of the small vessels
Chronic Recurrence  of acute cases. Large areas of
ischemia, necrosis and bone sequestra
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Table 2 – Cierny and Mader classiﬁcation of
osteomyelitis.
Characteristics
Anatomical stage
1  – Medullary Infection restricted to the bone marrow
2  – Superﬁcial Infection restricted to cortical bone
3  – Localized Infection with clearly deﬁned edges and
bone stability preserved
4 – Diffuse Infection spread to the entire bone
circumference,  with instability before or
after debridement
Classiﬁcation of the host
A  – Host healthy Patient  without comorbidities
Bl – Local
compromise
Smoking,  chronic lymphedema, venous
stasis, arthritis, large scars, ﬁbrosis by
radiotherapy
Bs – Systemic
compromise
Diabetes  mellitus, malnutrition, renal or
hepatic failure, chronic hypoxia,
neoplasms,  extremes of age
C  – Poor clinical Surgical  treatment will have higher riskAdapted from Ref. 2.
he medical approach to different types of osteomyelitis, aim-
ng  to obtain better clinical outcomes and at reducing the
ocial  costs of this disease. Acute and chronic osteomyelitis
re  discussed, with presentation of the general epidemiolog-
cal  concepts and the commonly used classiﬁcation systems.
he  main guidelines for clinical, laboratory and imaging diag-
osis  of infections are discussed, as well as the guidelines for
urgical  and antimicrobial treatments, and the role of hyper-
aric  oxygen as adjuvant therapy.1 The conclusions of this
ultidisciplinary review are summarized below.
I.  Which classiﬁcation should be used?
1. An ideal classiﬁcation of osteomyelitis should consider
the  different aspects that inﬂuence its pathophy-
siology, addressing all the possible etiologies and
parameters of temporal evolution. It should also be
closely correlated with the histological data and should
include proposals for the treatment of each classiﬁ-
cation stage. In general, the Waldvogel classiﬁcation2
is recommended for its greater clinical applicability,
and the Cierny and Mader classiﬁcation3 for its clearly
deﬁned surgical treatment proposals (Tables 1 and 2).
II.  Which subsidiary tests are important for the diagnosis of
osteomyelitis?
2.  The diagnosis of osteomyelitis considers a range of
clinical signs and symptoms, laboratory tests, imaging
studies and histological analyses, as well as the identi-
ﬁcation of pathogens by means of bone tissue or blood
cultures.
3.  In terms of laboratory tests, serum leukocyte count and
inﬂammatory markers, such as erythrocyte sedimen-
tation rate (ESR) and C-reactive protein (CRP), can assist
in  the initial diagnosis of osteomyelitis. However, these
are  non-speciﬁc tests and are more  useful in the control
of  treatment.
4.  The histology of biological samples should be carried
out  in all suspect cases, and bone biopsy, soft tis-
sue, and bone sequestra can conﬁrm the diagnosis of
osteomyelitis.conditions than the osteomyelitis itself
Adapted from Ref. 3.
5. A deﬁnitive diagnosis of osteomyelitis is obtained with
microbiological identiﬁcation of the pathogen in bone,
through a bone biopsy. Samples obtained through
swabs of the ﬁstula or secretions for use in cultures will
result  in false positive results, as they identify microor-
ganisms that colonize the skin. At least three different
samples of bone tissue should be obtained, in order to
increase  the positivity of the test. Antimicrobial ther-
apy  should be started after collecting culture samples
or  at the same time as anesthetic induction. Patients
should stop any antibiotics two weeks before collecting
culture samples, if possible. In cases of osteomyeli-
tis with osteosynthesis or in infected arthroplasties,
sonication of the implants signiﬁcantly increases the
identiﬁcation of pathogens.
6.  The use of complementary imaging methods can be
important in the early diagnosis of osteomyelitis. It
can  also assist in rapid start of treatment and follow-
up, enabling ineffective treatments to be modiﬁed.
In acute osteomyelitis, a plain radiography shows
osteomyelitis only after two weeks. Magnetic reso-
nance imaging (RMI) is considered the main type of
imaging in the evaluation of bone infections, as it
can  detect osteomyelitis as early as three to ﬁve days
of  infection. Computed tomography (CT) is of little
use in the diagnosis of acute infection, but is impor-
tant for investigating bone sequestra and planning
surgery. Three-phase bone scintigraphy, scintigraphy
with Gallium-67 and the positron emission tomo-
graphy (PET-CT) are examinations that help in the
differentiation of doubtful cases.
III. What  are the recommendations for the treatment of
osteomyelitis?
7.  The success of osteomyelitis treatment, particularlyin cases related to implants, is closely linked to
extensive surgical debridement and adequate antibi-
otic  therapy.
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8. Starting empirical antibiotics in anesthetic induc-
tion prevents the risks of bacteremia arising from
surgical manipulation of infection without adequate
antibiotic coverage. Yet, it does not interfere with
the positivity of cultures taken during the procedure.
Empirical antibiotic can also be started after collecting
culture samples in non-septic patients.
9. Empirical coverage of Staphylococcus aureus is recom-
mended, given the epidemiological importance of this
agent.  The local prevalence of methicillin resistance,
even in community-acquired cases, is variable and
should also be observed.
10.  Acute infections can be treated initially with exten-
sive surgical cleaning associated with antibiotic
therapy lasting four to six weeks. Chronic infections
should be treated with extensive surgical debride-
ment, removal of any implants and antibiotic therapy
lasting three to six months.
Introduction
Osteomyelitis, which was  named by Nelaton in 1844, is one of
the  oldest reported diseases known to the scientiﬁc commu-
nity.  However, the available epidemiological data are scarce,
probably  due to the different pathophysiological mechanisms
involved in the genesis of the disease, which makes it difﬁ-
cult  to estimate the incidence and prevalence in the general
population.4,5
Osteomyelitis can be deﬁned as an inﬂammation of the
bone  tissue caused by an infectious agent. This infection may
be  hematogenic, contiguous to an adjacent infectious focus,
or  even the result of direct bacterial inoculation from a trau-
matic  mechanism. In general, hematogenous osteomyelitis is
caused by a single agent, while other types can show polymi-
crobial  infection.6,7 Hematogenous osteomyelitis has more
consolidated data in the medical literature, and is considered
a  predominantly pediatric disease, with 85% of patients aged
below  17 years.8 In adult patients, it is estimated that 47–50%
of  all osteomyelitis are post-traumatic. Vertebral osteomyelitis
occurs  in 2–7% of patients.4,9
Chronic osteomyelitis represents a major health problem
due  to its signiﬁcant morbidity and low mortality rate.3,5,8,10
This infection occurs in approximately 5–50% of open frac-
tures,  in less than 1% of closed fractures with osteosynthesis,
and in 5% of acute hematogenous disease.5 The main prob-
lem  associated with chronic bone infection is the capacity of
the  microorganisms to remain in necrotic bone tissue for long
periods, especially in tissues that has not undergone adequate
surgical  debridement.
Classiﬁcation  systems  for  osteomyelitis
Osteomyelitis is a highly heterogeneous disease in its clinical
presentation, pathophysiology and treatment. The vari-
ous  clinical syndromes that comprise this entity, although
grouped under the same name, should be classiﬁed according
to  their common characteristics, enabling standardization of 1 4;1  8(5):526–534
conducts and comparison of the outcomes of different clinical
studies.11
Various classiﬁcation systems have been described in the
medical  literature, and the adoption of any one should be suit-
able  for the particularities of each treatment center. Recently,
new  classiﬁcations have been described.12 However, further
clinical  studies are needed before they can be adopted. In
general,  the Waldvogel classiﬁcation2 is recommended for its
greater clinical applicability, and the Cierny and Mader3 clas-
siﬁcation  for its clearly deﬁned treatment proposals.
Waldvogel  classiﬁcation
This classiﬁcation was  described in 1970 and is still the most
important  and widely used system in clinical studies. The
authors  divide osteomyelitis according to its physiopathology
and the duration of infection. Based on the physiopathol-
ogy, infections are classiﬁed into three groups: hematogenous
osteomyelitis; osteomyelitis secondary to a contiguous focus
of  infection; and osteomyelitis associated with peripheral vas-
cular insufﬁciency (Table 1). Based on the length of evolution,
the  infections are classiﬁed as acute osteomyelitis and chronic
osteomyelitis (recurrences). The authors do not determine a
time of evolution that would distinguish between chronic and
acute  cases.
Cierny  and  Mader  classiﬁcation
The Cierny and Mader classiﬁcation was described in 1984, as
an attempt to address some aspects that were  not covered by
previous classiﬁcations. In this classiﬁcation, osteomyelitis is
divided according to bone anatomy and physiological factors
of  the host (Table 2). The authors describe four anatomical
stages, according to the bone involvement, and three types
of  host, depending on the patient’s clinical conditions. It was
developed  mainly for infections in long bones.
Diagnosis
Correct diagnosis of bone infections presents many  difﬁcul-
ties,  as many  tests are not widely standardized. The clinical
signs  and symptoms, along with the inﬂammatory markers,
are  also nonspeciﬁc. Imaging examinations may  elucidate
very  little in the acute phase of the disease and may not
be  very speciﬁc in the chronic phase, and obtaining tissue
samples  for culture does not always help conﬁrming the diag-
nosis.  Diagnosis of osteomyelitis requires a set of clinical signs
and  symptoms, laboratory tests, imaging studies, histologi-
cal  analysis and, ﬁnally, the identiﬁcation of pathogens by
means  of bone tissue or blood cultures, particularly in cases
of  hematogenous osteomyelitis.13
Clinical suspicion is critical to start medical investigation,
and its manifestations depend on several factors, such as the
length  of infection (acute or chronic), infection site and type
of  bone involved.13,14In acute forms of osteomyelitis and in those of hematoge-
nous origin, local symptoms, such as pain, heat, edema, and
hyperemia,  and systemic symptoms, such as fever, general
malaise,  and adynamia, appear up to two weeks after the
 2 0 1 
i
e
p
f
h
t
s
h
m
L
A
n
o
a
c
i
c
o
e
m
a
H
S
f
a
a
d
a
o
t
b
t
a
o
M
A
i
s
s
a
i
a
s
t
t
e
p
o
c
s
p
Tb r a z j i n f e c t d i s .
nitial infection. However, the clinical presentation of the dis-
ase can be quite variable. Diagnosis is easier in patients who
resent  cutaneous ﬁstula or open wound with bone exposure
ollowing  open fractures, but very difﬁcult in patients who
ave  only progressive pain.14 In chronic forms of osteomyeli-
is,  the clinical presentation is highly variable. The systemic
ymptoms are usually absent and the local symptoms, such as
yperemia, heat, edema and ﬁstulization, often appear inter-
ittently,  or even years after the beginning of bone infection.14
aboratory  tests
cute infections are often associated with leukocytosis and
eutrophilia  – a change that is rarely found in chronic
steomyelitis. Inﬂammatory markers, such as ESR and CRP,
re  often elevated in acute hematogenous osteomyelitis in
hildren.  However, these are nonspeciﬁc tests and are more
mportant  in the control of treatment.15,16 The serum procal-
itonin levels for the diagnosis or follow-up of hematogenous
steomyelitis in children or in diabetic patients did not prove
ffective  in several studies.17–19 Serum level of interleukin-6 is
ost  commonly studied as a diagnostic tool of bone infections
ssociated with joint prosthesis.20
istological  tests
amples of bone, soft tissue and bone sequestra should be sent
or  histological analysis after biopsy or surgical debridement,
s  these can conﬁrm the diagnosis of osteomyelitis.14,21,22 In
cute  osteomyelitis, polymorphonuclear leukocytes are pre-
ominant,  while in chronic forms, lymphocytes, osteoblasts
nd  osteoclasts are predominant.21 In suspicious cases of
steomyelitis, histological examination may  lead to diagnos-
ic  conﬁrmation in up to 50% of patients.23 Frozen samples of
one  tissues obtained during surgery with more  than ﬁve neu-
rophils  per ﬁeld present sensitivity ranging from 43% to 84%
nd  speciﬁcity of 93–97% in bone infections associated with
rthopedic  implants.14,24
icrobiological  tests
t least three bone samples should be obtained, in order to
ncrease  the positivity rate of the test. Antimicrobial therapy
hould  be started after collecting culture samples or at the
ame  time as anesthetic induction.22,23 Patients should stop
ny  antibiotics two weeks before collecting culture samples,
f  possible. Slow-growing bacteria, such as Propionibacterium
cnes, may  be associated with osteomyelitis with osteosynthe-
is,  and in these cases it is important to prolong the incubation
ime  of the culture plates for up to 14 days.25 In fact, bone cul-
ures  can produce false-negative results in up to 40% of cases,
specially  in patients using antibiotics.26
Sonication signiﬁcantly increases the identiﬁcation of the
athogens  when osteomyelitis occurs in the presence of
steosynthesis, including infected arthroplasties. Sonication
onsists  of subjecting the implants to low-frequency ultra-
ound,  and consequent rupture of protective extracellular
olymeric surface over the bacteria contained in the bioﬁlms.
he  bacteria, thus released from the bioﬁlms into the liquid4;1 8(5):526–534  529
medium,  remain viable and are cultivated in solid and liquid
culture  media.27
Imaging  diagnosis  and  nuclear  medicine
In acute osteomyelitis, initial plain radiography does not show
any  changes. After around three to four days there may  be an
increase  in soft tissues. Bone changes appear after two weeks,
and  poorly delineated lytic lesions can also be observed, sim-
ulating  an aggressive lesion. A lamellar periosteal reaction
is  also evident. Plain radiographies have a positivity rate of
only  20% after two weeks, but are necessary to rule out other
orthopedic  illnesses (tumors, fractures).28,29
MRI is considered the main type of imaging in the eval-
uation  of bone infections, revealing changes as early as the
ﬁrst  few days of the disease. Bone marrow edema is also
evident  in MRI (as poorly deﬁned areas of hyposignal in T1-
weighted  sequences and hypersignal in T2, with post-contrast
enhancement). As the disease progresses, abscesses appear,
with  typical peripheral enhancement in the contrast phase.
In  children, the infection characteristically crosses the growth
cartilage,  unlike neoplastic changes. The speciﬁcity of MRI
is  higher than that of bone scintigraphy in the diagnosis of
infection.30–32
CT is of little utility in the diagnosis of acute infection.
Its role is restricted to the study of bone sequestra in case of
subacute  and chronic infections, indicating potential infection
activity.33,34
Ultrasound examination may  be of use, especially in
younger patients, as it reveals edema of the soft tissues
around the bone, periosteal thickening, and subperiosteal col-
lections. An area of hyperemia can also be observed in the
color  Doppler. This method provides very little data on intra-
osseous  extension, and is of limited use in this regard.30,35
Imaging methods are of little utility in the therapeutic
management of bone infections. Radiographic changes may
still  be present, despite adequate treatment. In these cases,
functional methods, especially PET-CT, play a more  important
role.33,34,36
Nuclear medicine uses radiotracers with known biological
properties in order to outline an image  of a physiologi-
cal process of the organism. Some of the most common
indications of nuclear medicine methods are in cases of sus-
pected  osteomyelitis with doubtful clinical or radiographic
signs, when there are image  artifacts in the radiological
methods and in the developmental follow-up or response to
treatment.29,37,38
PET-CT is a technique that uses positron-emitting iso-
topes  to form images, the main one being ﬂuorine-18-labeled
ﬂuorodeoxyglucose. It provides improved spatial resolution,
better  sensitivity, and better speciﬁcity when compared to
conventional  scintigraphy (96% and 91%, respectively). It can
be considered one of the best techniques in nuclear medicine,
but  it is a high-cost examination and is only available in a few
diagnostic  centers, which limits its use.
Bone scintigraphy is an examination that has histori-
cally been used to differentiate osteomyelitis from soft tissue
infections.  It uses diphosphonate radiotracers marked with
technetium-99 metastable isotope (99mTc), methylene diphos-
phonate  (99mTc-MDP) being one of the most commonly used.
i s . 2 0 1 4;1  8(5):526–534
Table 3 – Bone penetration of antibiotics.
Antibiotic Time interval
since  last dose
(h)
Bone/serum
concentration
ratio
Amoxycillin 2 0.17–0.31
Amoxycillin + clavulanate 0.5–6 0.01–0.09
Ampicillin 0.25–4 0.11–0.71
Sulbactam 0.25–4 0.11–0.71
Piperacillin 1 0.18–0.23
Tazobactam 1 0.22–0.26
Oxacillin 1 0.11
Ertapenem 1.6–23.8 0.13–0.19
Ceftriaxone 0.2–8 0.07–0.17
Cefazolin 0.9 0.17
Cefepime 1–2 0.46–0.76
Ceftazidime 2 0.54
Erythromycin 0.25–2 0.18–0.28
Azithromycin 0.5–6.5 days 2.5–6.3
Clindamycin 1–2 0.21–0.45
Rifampin 2–14 0.08–0.56
Rifampin (osteomyelitis) 3.5–4.5 0.57
Tigecycline 4–24 0.35–1.95
Levoﬂoxacin 0.7–2 0.36–1.0
Ciproﬂoxacin 0.5–13 0.27–1.2
Ciproﬂoxacin (osteomyelitis) 2–4.5 0.42
Vancomycin 0.7–6 0.05–0.67
Vancomycin (osteomyelitis) 1–7 0.27
Linezolid 0.5–1.5 0.4–0.51
Linezolid (osteomyelitis) 0.9 0.23
Daptomycin 2 1.08530  b r a z j i n f e c t d 
It is performed in the so-called three-phase mode: the ﬁrst
ﬂow  phase with dynamic images acquired immediately after
intravenous  injection of the radiotracer, for 1 min; the sec-
ond  phase, steady-state, with static images of the region of
greatest  interest, acquired 5 min  after injection of the radio-
tracer;  and the third phase, the late phase, with whole-body
images, acquired after 2 h of injection of the radiotracer. It
presents  reasonable sensitivity (70–89%), but low speciﬁcity
(16–36%).32–34
Gallium scintigraphy uses gallium-67 citrate, an iron ana-
log  radiotracer that concentrates in inﬂamed tissues due to
the higher blood ﬂow and increased concentration of trans-
ferrin,  to which it binds. It should be used in conjunction with
bone  scintigraphy for the evaluation of cases of osteomyelitis,
where it shows a greater uptake of the radiotrace and infers
the  presence of active infectious process.39
Indium-111 marked leukocyte scintigraphy is considered
the  best method of nuclear medicine for assessing patients
with  osteomyelitis, because it is independent of bone remod-
eling.  Because it is a high-cost procedure, and complex to
implement,  it is available in very few diagnostic centers. It
shows  good sensitivity (84%) and speciﬁcity (80%).28
Antimicrobial  treatment
The rate and extent of antibiotic penetration in bone tissues
are  seen as determining factors for therapeutic success in
osteomyelitis.40 On the other hand, penetration of an antibi-
otic  into infected bone tissue depends on its pharmacological
characteristics, the degree of vascularization, good conditions
of  soft tissues, and the presence of foreign bodies.41 Inte-
grating  information related to tissue concentration in clinical
practice  is a stumbling block in the process of antimicrobial
selection for the treatment of bone infections.
Antibiotics  with  a  high  bone/serum  concentration  ratio
The decision on the clinical usefulness of an antibiotic in
osteomyelitis should combine studies on bone concentra-
tion  with the results of clinical studies in patients with
osteomyelitis.40,42
The majority of bone penetration studies are performed
in  patients undergoing hip replacement surgery, and sam-
ples  obtained are from uninfected bones. With this in mind,
Table  3 40,42 shows the bone concentration of the antibiotics
presented in clinical studies not involving humans.
Therapeutic  regimens  in  acute  and  chronic  infections
The success of osteomyelitis treatment, particularly in cases
related  to implants, depends on extensive surgical debride-
ment  and adequate and effective antibiotic therapy.43,44
Starting empirical antibiotics in anesthetic induction prevents
the  risks of bacteremia arising from surgical manipulation of
infection  without adequate antibiotic coverage. Yet, it does not
interfere  with the positivity of cultures taken during the pro-
cedure.  Empirical antibiotic can also be started after collecting
culture  samples in non-septic patients.Teicoplanin 4–16 0.5–0.64
Adapted from Refs. 40, 42.
The duration of antibiotic therapy varies from four weeks
to  six months, and the treatment should be adjusted based
on  the results of the cultures collected, where necessary.45,46
Acute infections can be treated initially with extensive surgi-
cal  cleaning associated with antibiotic therapy lasting four to
six weeks.
Chronic infections should be treated with extensive sur-
gical  debridement and removal of any synthesis materials,
which can be replaced during the same surgical procedure if
there is orthopedic indication. Due to bioﬁlm formation, the
total  administration time of antibiotics in these infections is
three to six months.47 See Table 4.
Special  antimicrobial  –  rifampin
There is no antimicrobial regimen that is perfect for every sit-
uation.  The ability of rifampin in erradicating slow-growing
bacteria in bioﬁlms is well known. Thus, the suggestion to
add  rifampin to another drug with activity against S. aureus
is  recurrent in the literature, but this drug should never be
used  as monotherapy.48
Surgical  treatment
Hematogenous  osteomyelitisIn order to optimize the surgical treatment of osteomyelitis,
it  is essential to stage the disease correctly. This includes
b r a z j i n f e c t d i s . 2 0 1 4;1 8(5):526–534  531
Table 4 – Suggested empirical initial antimicrobial regimens for osteomyelitis.
Clinical situation Initial antimicrobial Possible oral regimens
Community
associated
Acute (child < 4 months or
NB)
Oxacillin, cefazolin or
clindamycina + ceftazidime
or cefepime
Starting oral treatment in this situation is not
recommended. After obtaining the culture results,
the regimen is adjusted
Acute (child > 4 months or
NB)
Oxacillin or cefazolina Starting oral treatment in this situation is not
recommended. After obtaining the culture results,
the regimen is adjusted
Acute adults Oxacillin or cefazolin Starting oral treatment in this situation is not
recommended. After obtaining the culture results,
the regimen is adjusted
Healthcare associated Child and adults (for
example,  infection after
fracture  ﬁxation)
Glycopeptide + ceftazidime,
cefepime,
iperacillin/tazobactan or
carbapenem  agentsb
Starting oral treatment in this situation is not
recommended. After obtaining the culture results,
the regimen is adjusted
Hemoglobinopathy Salmonella spp. and other
GNBs  should be considered
Ceftriaxone  or
ﬂuoroquinolone
Fluoroquinolone
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ra Considering local prevalence of CA-MRSA.
b Considering local patterns of bacterial susceptibility.
nvestigating inﬂammatory activity and culture tests, and
onducting  imaging examinations.49–52 Sometimes infection
n  the pediatric age group can be confused with other onco-
ogical  diseases that occur in this age group.53
Surgical treatment is mandatory when abscess is present.
urgical  drainage associated with debridement is performed
fter  conﬁrmation of the diagnosis by bone biopsy in the oper-
ting  room, with all the resources of asepsis and antisepsis.54
The surgical approach may  be open surgery, arthroscopy or
uncture/aspiration and ﬂushing. The use of ﬂushing under
xcessive  pressure should be avoided, because in addition to
ausing injury to the soft parts and bone, the pressure can
noculate  microorganisms deeply into the tissues.
Adequate debridement is the best predictor of success in
he  treatment of osteomyelitis. The surgical approach should
e  of the “oncology” type, i.e. with broad resection. Nowa-
ays,  a wide variety of surgical techniques are available for
he  reconstruction of both bone and soft tissues.49,52,54
cute  post-traumatic  osteomyelitis
he treatment of acute osteomyelitis is surgical, particularly
n  the presence of an implant, because early bacterial identiﬁ-
ation  and effective debridement are the only ways to save this
mplant. The surgeon should heed the clinical signs of a pos-
ible  infection. During the postoperative period, when there
re  pain, local hyperemia, inﬂammation, serous exsudate and
uspicion  of a hematoma at the surgical site, the surgeon must
ct  quickly, taking the patient back to the operating room for
ebridement  and cultures.55
The most important factor for a successful treatment of
atients  with bone infection is the quality of debridement. The
ebridement  must achieve a clean and viable wound through a
on-traumatic exposure. In acute infection, surgical drainage
nd  copious ﬂushing of the cavity signiﬁcantly reduce bacte-
ial  load at the site. Flushing should be performed with saline
olution,  with a total volume of 3–9 L, and there is a direct rela-
ionship  between the amount of saline solution used and the
eduction  of bacterial load.56–58In situations in which there is a dead space after
the removal of devitalized tissues, the use of polymethyl-
methacrylate cement impregnated with an antibiotic for local
release  is a good option. The high local concentration of antibi-
otics  obtained using this technique is far above the MIC  for
the  majority of microorganisms, and it would be impossi-
ble  to achieve this concentration with the use of systemic
antibiotics, due to associated toxicity. The antibiotics used in
bone cement must not be thermolabile, due to the exothermic
reaction of polymerization of polymethylmethacrylate, which
inactivates  these agents.59,60
Chronic  osteomyelitis
In the approach to a patient with chronic osteomyelitis, the
choice  between palliative treatment and a curative approach
should  be considered. Surgery is currently the only form of
cure  in almost all cases; however, it is not always the best
option.  Therefore, a multidisciplinary approach is important
in  the assessment of each case, in order to decide on the best
treatment.
The  steps in the treatment of chronic osteomyelitis con-
sist  of correct microbiological diagnosis; improvement of
the  host’s defenses; stabilization of underlying diseases; cor-
rect  anatomical localization of bone involvement; adequate
antimicrobial therapy; surgical debridement of all devitalized
tissue;  repair of soft tissues; and bone reconstruction and
rehabilitation.6
All devitalized tissues need to be removed, and the sur-
gical  technique used will depend on the extent of the bone
lesion.57,61–67 Wound closure by any means is imperative
when vital structures (e.g., vessels, nerves, tendons, bone) are
exposed, which may  often require local ﬂaps, or more  com-
plex  ﬂaps located further away (microsurgical). Only complete
resection  of all the devitalized tissues, with the establishment
of  adequate blood ﬂow, will lead to effective systemic antimi-
crobial  therapy and resolution of the infection. A resection
margin of 5 mm55 should be respected.
The  use of antibiotic-coated cement may  be an option
in  cases where there is dead space to be ﬁlled after the
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debridement and before the site is deﬁnitively closed. Com-
mercially  available antibiotic-impregnated cement spacers
may  be used for this purpose, but manual mixing of the antibi-
otic  cement at the time of use is possible. The most commonly
used  antibiotic is vancomycin at a dosage of 2–4 grams per 40 g
of cement. Other antibiotics may  also be used, provided they
are  not thermolabile, due to the exothermic reaction of the
polymethylmethacrylate.59,60
Another measure is the use of vacuum-assisted closure,
which has shown excellent results. Its correct use can sig-
niﬁcantly  improve the condition of the soft tissue wound in
terms  of its granulation, characteristics of vascularization, and
reducing  its size.68–70
Adjuvant  treatment  –  HBO
Hyperbaric oxygen therapy (HBO) is a form of adjuvant ther-
apy  that has been used worldwide for more  than sixty years.71
It is used in patients with infectious, inﬂammatory, immuno-
logical,  and ischemic tissue changes. The treatment involves
respiration of 100% oxygen under hyperbaric conditions, i.e.
under  pressures artiﬁcially elevated above the atmospheric
pressure at sea level, with the patient being placed inside a
pressure-resistant hyperbaric chamber. In this setting, large
quantities  of oxygen under pressure penetrate the blood,
are  dissolved in the plasma, and reach the tissues. Tissue
hyperoxygenation causes speciﬁc therapeutic effects, includ-
ing  stimulation of bacterial lysis by leukocytes, increase in
proliferation  of ﬁbroblasts and collagen, and neovasculariza-
tion of ischemic or irradiated tissues. The effects of HBO,
such  as immunomodulation,72 reduction in pro-inﬂammatory
mediators, and reduction in effects of ischemia-reperfusion73
in ischemic tissues, are extremely useful for the treatment
of  infections. The use of hyperbaric oxygen (O2HB) is asso-
ciated  with all the other therapeutic measures, making them
more  effective. Wound healing time is accelerated, the esthetic
results  are better, and the ﬁnal cost of treatment is also
reduced.1
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